MR in Drug Research Study Group

Tuesday, 4 May 2010
18:15 to 20:15
Room A7

18:15 Business Meeting
18:30 The Great Debates in MR in Drug Research
18:30 MRI for Body Composition Assessment Has Little Value for Drug Development Studies
Moderator: Bradley Wyman, Ph.D.
Pro: Paul Hockings, Ph.D., TBD Con: Jeff Evelhoch, Ph.D., TBD
19:05 MRI is a Superior Modality for Assessing Rheumatoid Arthritis or Osteoarthritis Disease Progression in Drug Related Studies
Moderator: TBD
Pro: Joshua Farber, M.D., Bradley Wyman, Ph.D. Con: Derek Hill, Ph.D., John Waterton, Ph.D.
19:40 The Use of MRI for Oncology Drug Trials Should be Severely Limited
Moderator: John Hazle, Ph.D.
Pro: Edward Ashton, Ph.D., TBD Con: Yanping Luo, Ph.D., TBD
20:15 Adjourn

Back to Main Meeting

Back to Home